Last reviewed · How we verify
Red blood cells unit age 14 days or less — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Red blood cells unit age 14 days or less (Red blood cells unit age 14 days or less) — Abdelrady S Ibrahim, MD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Red blood cells unit age 14 days or less TARGET | Red blood cells unit age 14 days or less | Abdelrady S Ibrahim, MD | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Red blood cells unit age 14 days or less CI watch — RSS
- Red blood cells unit age 14 days or less CI watch — Atom
- Red blood cells unit age 14 days or less CI watch — JSON
- Red blood cells unit age 14 days or less alone — RSS
Cite this brief
Drug Landscape (2026). Red blood cells unit age 14 days or less — Competitive Intelligence Brief. https://druglandscape.com/ci/red-blood-cells-unit-age-14-days-or-less. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab